Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 24, 2026
Why Is Concentrix Corporation (CNXC) Stock Down -11% Today?

Why Is Concentrix Corporation (CNXC) Stock Down -11% Today?

Key Takeaways

  • Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open.
  • Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
  • Net income plunged 69.3% year-over-year, and operating income fell 29.8%, signaling severe profitability compression despite top-line growth.
  • Revenue of $2.50 billion grew 5.4% year-over-year but fell short of certain analyst estimates near $2.54 billion.
  • Full-year fiscal 2026 guidance was maintained, not raised — viewed by markets as lacking the upside surprise needed to justify the pre-earnings run-up.
  • Investors will be watching the 8:30 a.m. ET earnings call closely for management commentary on margin recovery and debt management.

Opening Summary

Concentrix Corporation (CNXC) is a global leader in customer experience (CX) management and technology-enabled business services, serving clients across industries including technology, financial services, retail, and healthcare. Shares are trading approximately 11% lower in Tuesday premarket activity, declining to roughly $28.05 from the prior session's close of approximately $31.52, following the release of disappointing fiscal Q1 2026 results.  While headline revenue grew year-over-year, the print revealed a dramatic deterioration in profitability that rattled investors — net income fell 69.3% versus the same period last year.  The earnings-driven selloff reflects deepening concerns about CNXC's margin trajectory in a highly competitive, cost-intensive CX landscape.

Earnings Miss on Profitability

Concentrix reported fiscal Q1 2026 revenue of $2,500.4 million, up 5.4% year-over-year from $2,372.2 million, but falling short of some analyst estimates pegged near $2.54 billion.   On the bottom line, adjusted diluted EPS of $2.61 missed the consensus of approximately $2.64 — a modest figure in isolation, but one that, when paired with the broader profitability collapse, intensified investor concern.  The slight top-line beat versus the company's own guidance range of $2.475–$2.500 billion offered little consolation given the scale of margin deterioration elsewhere in the report.

Profitability Under Severe Pressure

The most alarming figures came from within the income statement. Operating income fell 29.8% year-over-year to $118.6 million, compared with $168.9 million in Q1 2025.  Net income declined an even steeper 69.3%, a figure that markets viewed as alarming rather than temporary.  Adjusted EBITDA came in at $348.2 million versus $374.2 million in the prior-year period — a roughly 7% decline even in the company's most favorable profitability metric.  These figures reflect what management has framed as transition-related headwinds, including costs tied to its acquisition-integration program and an ongoing operational transformation.

Guidance: Maintained, Not Upgraded

Concentrix reiterated its full fiscal year 2026 outlook, maintaining non-GAAP diluted EPS guidance of $11.48 to $12.07 and revenue of $10.04 billion to $10.18 billion.  While guidance maintenance signals management's confidence in hitting full-year targets, it provided no upward revision to lift sentiment. This proved to be a critical disappointment: ahead of the report, CNXC shares had surged nearly 5% to $33.04 in early premarket trading, implying elevated investor expectations.  The sharp reversal after the results points to the market penalizing the company for failing to deliver any forward-looking catalyst alongside profitability weakness.

Market Context and Trading Activity

The sell-off arrives at a particularly vulnerable moment for CNXC shares, which entered today's session already down more than 20% year-to-date and approximately 50% below their 52-week high of $65.04, reached in early 2025.  The stock has experienced several significant single-session drops in recent months, including a 6.1% decline in mid-March and a 5.1% drop in early March, establishing a pattern of weak price action.   Today's gap-down is expected to bring dramatically elevated volume when the regular session opens, as the size of the premarket move will attract both liquidation by institutional holders and tactical interest from contrarian buyers. The broader technology and business services sector has not experienced similar pressure, reinforcing that this is a company-specific earnings event rather than a macro- or sector-driven move.

Trending AI Robots

For traders navigating volatile earnings moves like today's in CNXC, Tickeron's Trending AI Robots page offers a curated look at the platform's top-performing automated trading strategies. Tickeron operates hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this dedicated section. The bots vary by strategy type, risk profile, timeframe, and the specific symbols they trade — giving traders a data-driven starting point for finding approaches suited to today's environment. Whether you favor short-term momentum plays around earnings or more measured swing-trading strategies, exploring the Trending AI Robots page can help identify AI-driven strategies that align with your objectives.

What Comes Next for CNXC

The immediate focus shifts to the earnings conference call at 8:30 a.m. ET on March 24, where Concentrix management will need to address the scale of profitability deterioration and outline a credible path toward margin recovery.  Key investor questions will center on the speed of cost rationalization, the margin contribution of AI-enhanced CX services, and how the company plans to manage its leverage — with a debt-to-equity ratio near 1.67, interest expense remains a material drag.  Analysts currently maintain a consensus "Hold" rating with price targets well above current trading levels, reflecting a view that long-term value exists but near-term execution risk remains elevated.  Until CNXC demonstrates consistent improvement in operating and net margins over successive quarters, sentiment is likely to remain cautious. The next earnings report is expected in Q2 2026, and any upward guidance revision at that point would be a key potential re-rating catalyst.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CNXC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


CNXC in upward trend: price may jump up because it broke its lower Bollinger Band on September 28, 2026

CNXC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 37 of 44 cases where CNXC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 62 cases where CNXC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on CNXC as a result. In 59 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.

Following a +8.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNXC advanced for three days, in 210 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.

Bearish Trend Analysis

The 10-day RSI Indicator for CNXC moved out of overbought territory on September 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In 22 of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at 88%.

The Moving Average Convergence Divergence Histogram (MACD) for CNXC turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 28 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.

CNXC moved below its 50-day moving average on October 02, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CNXC crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNXC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for CNXC entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.575) is normal, around the industry mean (7.462). P/E Ratio (8.576) is within average values for comparable stocks, (67.645). Projected Growth (PEG Ratio) (0.323) is also within normal values, averaging (2.284). CNXC's Dividend Yield (0.057) is considerably higher than the industry average of (0.010). P/S Ratio (0.180) is also within normal values, averaging (141.758).

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. CNXC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 87 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNXC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 8.39B. The market cap for tickers in the group ranges from 100 to 207.9B. IBM holds the highest valuation in this group at 207.9B. The lowest valued company is ARSC at 100.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 2%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was -10%. JZ experienced the highest price growth at 214%, while OPNW experienced the biggest fall at -46%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was 63%. For the same stocks of the Industry, the average monthly volume growth was 82% and the average quarterly volume growth was 21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 64
Price Growth Rating: 61
SMR Rating: 73
Profit Risk Rating: 92
Seasonality Score: 9 (-100 ... +100)
View a ticker or compare two or three
CNXC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of active thermal coal operations

Industry InformationTechnologyServices

Industry
Coal
Address
39899 Balentine Drive
Phone
+1 800 747-0583
Employees
455000
Web
https://www.concentrix.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.